SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (25868)9/29/1998 10:37:00 PM
From: jayhawk969  Read Replies (3) | Respond to of 32384
 
Henry,

I am becoming skeptical of underwriters that plug Ligand. It obvious that Lehman and others derive significant fees from LGND SRGN and I assume Elan. What conflicts does Bear Stearns have in their disclosures?

J.D.



To: Henry Niman who wrote (25868)9/29/1998 11:08:00 PM
From: aknahow  Respond to of 32384
 
Henry, see no hint of a buyout. What specifically do you see that supports that post?

DISREGARD ABOVE!

O.K. see what you based it on. Yes it is a hint of something that might be of interest in the more distant future. If anything the deal also provides some immediate protection against other potential acquirers. This can be considered good or bad depending on ones point of view.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News